Augmedix (AUGX)
(Delayed Data from NSDQ)
$0.92 USD
+0.01 (0.94%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $0.92 0.00 (0.37%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth A Momentum C VGM
Income Statements
Fiscal Year end for Augmedix, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 45 | 31 | 22 | 16 | 14 |
Cost Of Goods | 23 | 17 | 12 | 10 | 9 |
Gross Profit | 22 | 14 | 10 | 7 | 5 |
Selling & Adminstrative & Depr. & Amort Expenses | 40 | 36 | 28 | 20 | 21 |
Income After Depreciation & Amortization | -19 | -22 | -18 | -14 | -17 |
Non-Operating Income | 2 | 0 | 3 | 0 | 1 |
Interest Expense | 2 | 2 | 3 | 1 | 3 |
Pretax Income | -19 | -24 | -18 | -16 | -19 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -19 | -24 | -18 | -16 | -19 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -19 | -24 | -18 | -16 | -19 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -18 | -22 | -17 | -13 | -16 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | 1 |
Income After Depreciation & Amortization | -19 | -22 | -18 | -14 | -17 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 43.95 | 37.42 | 28.92 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.44 | -0.62 | -0.62 | NA | NA |
Diluted Net EPS (GAAP) | -0.44 | -0.65 | -0.62 | -2.22 | NA |
Fiscal Year end for Augmedix, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 13.47 | 12.68 | 11.77 | 10.78 |
Cost Of Goods | NA | 7.13 | 6.44 | 5.94 | 5.72 |
Gross Profit | NA | 6.34 | 6.24 | 5.83 | 5.07 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 12.74 | 10.59 | 10.24 | 10.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -6.40 | -4.35 | -4.41 | -4.93 |
Non-Operating Income | NA | 0.44 | 0.48 | 0.72 | 0.51 |
Interest Expense | NA | 0.62 | 0.65 | 0.64 | 0.56 |
Pretax Income | NA | -6.58 | -4.51 | -4.32 | -4.98 |
Income Taxes | NA | -0.08 | -0.02 | 0.08 | 0.05 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -6.50 | -4.49 | -4.41 | -5.03 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -6.50 | -4.49 | -4.41 | -5.03 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 53.06 | 49.02 | 45.52 | 43.61 |
Diluted EPS Before Non-Recurring Items | NA | -0.12 | -0.09 | -0.10 | -0.12 |
Diluted Net EPS (GAAP) | NA | -0.12 | -0.08 | -0.10 | -0.12 |